May 18, 2020 / 10:15 AM / 8 days ago

BRIEF-Fulgent Genetics Receives Emergency Use Authorization From The FDA For Its RT-PCR Test For Detection Of SARS-CoV-2

May 18 (Reuters) - Fulgent Genetics Inc:

* FULGENT GENETICS RECEIVES EMERGENCY USE AUTHORIZATION FROM THE FDA FOR ITS RT-PCR TEST FOR DETECTION OF SARS-COV-2, THE VIRUS THAT CAUSES COVID-19

* FULGENT GENETICS - EUA ALLOWS FOR TEST TO BE USED WITH NASAL SWAB SPECIMENS WHICH CAN BE SELF-COLLECTED BY PATIENTS AT HOME

* FULGENT GENETICS - RT-PCR TEST GRANTED EUA BY FDA ONLY FOR DETECTION OF NUCLEIC ACID FROM SARS-COV-2, NOT FOR ANY OTHER VIRUSES OR PATHOGENS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below